New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 25, 2013
06:53 EDTTHRXTheravance upgraded to Outperform from Market Perform at Bernstein
Bernstein upgraded Theravance and views risk/reward as favorable ahead of Relvar and Anoro FDA/EMA decisions this year. Price target is $26.
News For THRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 18, 2015
16:40 EDTTHRXTheravance reports Q4 EPS (14c), consensus (15c)
Reports Q4 revenue $7.3M, consensus $5.42M.
15:35 EDTTHRXNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use